Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis

References

• Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst. 2017;109(9). doi:10.1093/jnci/djx007.
   Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortettieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Wang LY, Cui JJ, Guo AX, Yin JY. Therapy. Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients. Onco Targets Ther. 2018;11:529–538. doi:10.2147/OTT.S13657929416353
   PubMed Web of Science ®Google Scholar
• Herrmann H, Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu Rev Biochem. 2004;73:749–789. doi:10.1146/annurev.biochem.73.011303.07382315189158
   PubMed Web of Science ®Google Scholar
• Jacob JT, Coulombe PA, Kwan R, Omary MB. Types I and II keratin intermediate filaments. Cold Spring Harb Perspect Biol. 2018;10(4):a018275. doi:10.1101/cshperspect.a01827529610398
   PubMed Web of Science ®Google Scholar
• Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene. 2011;30(2):127–138. doi:10.1038/onc.2010.45620890307
   PubMed Web of Science ®Google Scholar
• Troyanovsky SM, Leube RE, Franke WW. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol. 1992;59(1):127.1281771
   PubMed Web of Science ®Google Scholar
• Matt VDR, Perou CM, Rob T, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002;161(6):1991–1996.12466114
   PubMed Web of Science ®Google Scholar
• SoRlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–10874. doi:10.1073/pnas.19136709811553815
   PubMed Web of Science ®Google Scholar
• Moll R, Divo M, Langbein LJH. The human keratins: biology and pathology. Cell Biol. 2008;129(6):705–733.
   Google Scholar
• Escobar-Hoyos LF, Yang J, Zhu J, et al. Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker. Mod Pathol. 2014;27(4):621–630. doi:10.1038/modpathol.2013.16624051697
   PubMed Web of Science ®Google Scholar
• Hu H, Xu DH, Huang XX, et al. Keratin 17 promotes tumor growth and is associated with poor prognosis in gastric cancer. J Cancer. 2018;9(2):346–357. doi:10.7150/jca.1983829344281
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang S, Wang G. Keratin 17 in disease pathogenesis: from cancer to dermatoses. J Pathol. 2018;247(2):158–165. doi:10.1002/path.517830306595
   PubMed Web of Science ®Google Scholar
• Chivu-Economescu M, Dragu DL, Necula LG, et al. Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells. Gastric Cancer. 2017;20(6):948–959. doi:10.1007/s10120-017-0712-y28299464
   PubMed Web of Science ®Google Scholar
• Savita S, Tanner JM, Russell B, et al. A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma. Mol Cell Biol. 2013;33(22):4448–4460. doi:10.1128/MCB.00241-1324043308
   PubMed Web of Science ®Google Scholar
• Rydlander L, Ziegler E, Bergman T, et al. Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem. 2010;241(2):309–314. doi:10.1111/j.1432-1033.1996.00309.x
   Google Scholar
• Stacy M, Pauline W, Paul M, Coulombe PA. Role for keratins 6 and 17 during wound closure in embryonic mouse skin. Dev Dyn. 2010;226(2):356–365.
   Google Scholar
• Mikami Y, Fujii S, Nagata K, et al. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas. J Cancer Res Clin Oncol. 2017;143(8):1381–1393. doi:10.1007/s00432-017-2398-228342001
   PubMed Web of Science ®Google Scholar
• Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem. 1998;31:205–262.9932494
   PubMedGoogle Scholar
• Goldstraw P. Updated staging system for lung cancer. Surg Oncol Clin N Am. 2011;20(4):655–666. doi:10.1016/j.soc.2011.07.00521986263
   PubMed Web of Science ®Google Scholar
• Wang Y, Lei L, Zheng YW, et al. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and beta-catenin. Cancer Sci. 2018;109(6):1799–1810. doi:10.1111/cas.1361429660200
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.00228732212
   PubMed Web of Science ®Google Scholar
• Nagy A, Lanczky A, Menyhart O, Gyorffy B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8(1):9227. doi:10.1038/s41598-018-27521-y29907753
   PubMed Web of Science ®Google Scholar
• Regenbogen E, Mo M, Romeiser J, et al. Elevated expression of keratin 17 in oropharyngeal squamous cell carcinoma is associated with decreased survival. Head Neck. 2018;40(8):1788–1798.29626364
   PubMed Web of Science ®Google Scholar
• Chen Y, Cui T, Yang L, et al. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer. Oncology. 2011;80(5–6):333–340. doi:10.1159/00032909821791943
   PubMed Web of Science ®Google Scholar
• Chiang CH, Wu CC, Lee LY, et al. Proteomics analysis reveals involvement of Krt17 in areca nut-induced oral carcinogenesis. J Proteome Res. 2016;15(9):2981–2997. doi:10.1021/acs.jproteome.6b0013827432155
   PubMed Web of Science ®Google Scholar
• Mikami T, Maruyama S, Abe T, et al. Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration. Virchows Archiv. 2015;466(5):559–569. doi:10.1007/s00428-015-1735-625736868
   PubMed Web of Science ®Google Scholar
• Cadigan KM, Peifer M. Wnt signaling from development to disease: insights from model systems. Cold Spring Harb Perspect Biol. 2009;1(2):a002881.20066091
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26. doi:10.1016/j.devcel.2009.06.01619619488
   PubMed Web of Science ®Google Scholar
• Niehrs C, Acebron SP. Mitotic and mitogenic Wnt signalling. Embo J. 2012;31(12):2705–2713. doi:10.1038/emboj.2012.12422617425
   PubMed Web of Science ®Google Scholar
• Nusse R, Varmus H. Three decades of Wnts: a personal perspective on how a scientific field developed. Embo J. 2012;31(12):2670–2684. doi:10.1038/emboj.2012.14622617420
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4(5):a008052. doi:10.1101/cshperspect.a00805222438566
   PubMed Web of Science ®Google Scholar
• Govaere O, Komuta M, Berkers J, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014;63(4):674–685. doi:10.1136/gutjnl-2012-30435123958557
   PubMed Web of Science ®Google Scholar